Literature DB >> 7228391

Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27.

P Kiley, S C Holt.   

Abstract

The lipopolysaccharide (LPS) from Actinobacillus actinomycetemcomitans strains Y4 and N27 was isolated by the phenol-water procedure. Morphologically, the molecule consisted of ribbon and branched filaments which comprised 3% of the cellular dry weight. Chemical analysis of the isolated and purified LPSs of both strains showed them to consist of carbohydrate, lipid, 2-keto-3-deoxyoctonate, heptose, hexosamine, and phosphate. The major fatty acids of the lipid A moiety were saturated C14 and beta-OH C14 compounds. Rhamnose, fucose, galactose, glucose, heptose, glucosamine, and galactosamine comprised the monosaccharide portion of the LPS. Biological activity studies revealed both LPS molecules to be active in the Schwartzman reaction and in in vitro 45Ca bone resorption, as well as in macrophage activation and lethality and in platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7228391      PMCID: PMC551394          DOI: 10.1128/iai.30.3.862-873.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Induction of bone resorption in tissue culture. Prolonged response after brief exposure to parathyroid hormone or 25-hydroxycholecalciferol.

Authors:  L G Raisz; C L Trummel; H Simmons
Journal:  Endocrinology       Date:  1972-03       Impact factor: 4.736

2.  The morphologic structure of isolated bacterial lipopolysaccharide.

Authors:  J W Shands; J A Graham; K Nath
Journal:  J Mol Biol       Date:  1967-04-14       Impact factor: 5.469

3.  The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium.

Authors:  J Schwartz; F L Stinson; R B Parker
Journal:  J Periodontol       Date:  1972-05       Impact factor: 6.993

4.  Effects of lipopolysaccharides on bone resorption in tissue culture.

Authors:  E Hausmann; N Weinfeld; W A Miller
Journal:  Calcif Tissue Res       Date:  1972

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  A simple method for the quantitation of submicrogram amounts of bacterial endotoxin.

Authors:  R E Pieroni; E J Broderick; A Bundeally; L Levine
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

7.  Chemical composition of lipopolysaccharide endotoxins from human oral fusobacteria.

Authors:  T Kristoffersen; T Hofstad
Journal:  Arch Oral Biol       Date:  1970-10       Impact factor: 2.633

8.  Immunologic reactions and periodontal inflammation.

Authors:  S E Mergenhagen; T R Tempel; R Snyderman
Journal:  J Dent Res       Date:  1970 Mar-Apr       Impact factor: 6.116

9.  Chemical characteristics of Bacteroides melaninogenicus endotoxin.

Authors:  T Hofstad
Journal:  Arch Oral Biol       Date:  1968-09       Impact factor: 2.633

10.  Endotoxin: stimulation of bone resorption in tissue culture.

Authors:  E Hausmann; L G Raisz; W A Miller
Journal:  Science       Date:  1970-05-15       Impact factor: 47.728

View more
  54 in total

1.  Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria.

Authors:  Ryousuke Yamano; Masaru Ohara; Shuichi Nishikubo; Tamaki Fujiwara; Toru Kawamoto; Yoko Ueno; Hitoshi Komatsuzawa; Katsuji Okuda; Hidemi Kurihara; Hidekazu Suginaka; Eric Oswald; Kazuo Tanne; Motoyuki Sugai
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.

Authors:  M Sugai; T Kawamoto; S Y Pérès; Y Ueno; H Komatsuzawa; T Fujiwara; H Kurihara; H Suginaka; E Oswald
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

3.  Specific antibody reactivity against a 110-kilodalton Actinobacillus actinomycetemcomitans protein in subjects with periodontitis.

Authors:  T F Fleming; I Selmair; H Schmidt; H Karch
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

4.  Precipitating antibody against lipopolysaccharide of Haemophilus actinomycetemcomitans in human serum.

Authors:  K Okuda; T Kato; Y Naito; I Takazoe
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  Aggregatibacter actinomycetemcomitans regulates the expression of integrins and reduces cell adhesion via integrin α5 in human gingival epithelial cells.

Authors:  Shinsuke Kochi; Keisuke Yamashiro; Shoichi Hongo; Tadashi Yamamoto; Yuki Ugawa; Masayuki Shimoe; Mari Kawamura; Chiaki Hirata-Yoshihara; Hidetaka Ideguchi; Hiroshi Maeda; Shogo Takashiba
Journal:  Mol Cell Biochem       Date:  2017-06-07       Impact factor: 3.396

6.  Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1beta mRNA expression through the JNK pathway in differentiated THP-1 cells.

Authors:  T Iwata; A Mitani; Y Ishihara; S Tanaka; G Yamamoto; T Kikuchi; T Naganawa; Y Matsumura; T Suga; M Koide; T Sobue; T Suzuki; T Noguchi
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

7.  Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  G Rabie; E T Lally; B J Shenker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

8.  Chemical and biological characterization of the lipopolysaccharide of the oral pathogen Wolinella recta ATCC 33238.

Authors:  J Gillespie; S T Weintraub; G G Wong; S C Holt
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  Role of the NK cell-activating receptor CRACC in periodontitis.

Authors:  Benjamin Krämer; Moritz Kebschull; Michael Nowak; Ryan T Demmer; Manuela Haupt; Christian Körner; Sven Perner; Søren Jepsen; Jacob Nattermann; Panos N Papapanou
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

10.  Selective medium for isolation of Actinobacillus actinomycetemcomitans.

Authors:  J Slots
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.